Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-03-26
DOI
10.1002/ijc.31400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit
- (2017) Jing Wang et al. NUCLEIC ACIDS RESEARCH
- Role of cancer stem-cell marker doublecortin-like kinase 1 in head and neck squamous cell carcinoma
- (2017) Lorenz Kadletz et al. ORAL ONCOLOGY
- The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
- (2017) Muhammad Zaeem Noman et al. OncoImmunology
- Renal cell carcinoma
- (2017) James J. Hsieh et al. Nature Reviews Disease Primers
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Abstract 577: Systemic delivery of CBT-15G DCLK1-targeted monoclonal antibody dramatically decreases tumorigenesis in a xenograft model of pancreatic cancer
- (2016) Nathaniel Weygant et al. CANCER RESEARCH
- Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem–like Cells Marked by DCLK1 Kinase
- (2016) Nathaniel Weygant et al. CANCER RESEARCH
- Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis
- (2016) C. Benedikt Westphalen et al. Cell Stem Cell
- PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung
- (2016) Sehui Kim et al. HUMAN PATHOLOGY
- Sunitinib activates Axl signaling in renal cell cancer
- (2016) Johannes C. van der Mijn et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma
- (2015) Yiwei Wang et al. MEDICAL ONCOLOGY
- Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
- (2015) Abdullah Alsuliman et al. Molecular Cancer
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- Tyrosine kinase inhibitors target cancer stem cells in renal cell cancer
- (2015) ANNA M. CZARNECKA et al. ONCOLOGY REPORTS
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- (2015) Adam Myszczyszyn et al. Stem Cell Reviews and Reports
- Sunitinib but not VEGF blockade inhibits cancer stem cell endothelial differentiation
- (2015) Alessia Brossa et al. Oncotarget
- DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
- (2015) Nathaniel Weygant et al. Oncotarget
- The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
- (2015) Adam Myszczyszyn et al. Stem Cell Reviews and Reports
- The recently suggested intestinal cancer stem cell markerDCLK1is an epigenetic biomarker for colorectal cancer
- (2014) Hege Marie Vedeld et al. Epigenetics
- Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas
- (2014) Shuji Mikami et al. INTERNATIONAL JOURNAL OF CANCER
- Long-lived intestinal tuft cells serve as colon cancer–initiating cells
- (2014) C. Benedikt Westphalen et al. JOURNAL OF CLINICAL INVESTIGATION
- Photoactivatable Glycopolymers for the Proteome-Wide Identification of Fucose-α(1-2)-Galactose Binding Proteins
- (2014) Arif Wibowo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
- (2014) Nathaniel Weygant et al. Molecular Cancer
- Acquired resistance to sunitinib in human renal cell carcinoma cells is mediated by constitutive activation of signal transduction pathways associated with tumour cell proliferation
- (2013) Iori Sakai et al. BJU INTERNATIONAL
- HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
- (2013) B. Philip et al. CARCINOGENESIS
- DCLK1 Marks a Morphologically Distinct Subpopulation of Cells With Stem Cell Properties in Preinvasive Pancreatic Cancer
- (2013) Jennifer M. Bailey et al. GASTROENTEROLOGY
- Expression and Prognostic Significance of a Comprehensive Epithelial-Mesenchymal Transition Gene Set in Renal Cell Carcinoma
- (2013) Dong Chen et al. JOURNAL OF UROLOGY
- Dysregulation of β-Catenin is an Independent Predictor of Oncologic Outcomes in Patients with Clear Cell Renal Cell Carcinoma
- (2013) Laura-Maria Krabbe et al. JOURNAL OF UROLOGY
- Increased expression of ALDH1A1 protein is associated with poor prognosis in clear cell renal cell carcinoma
- (2013) Kefeng Wang et al. MEDICAL ONCOLOGY
- Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line
- (2013) Kosuke Ueda et al. PLoS One
- Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy
- (2012) Ken-ichi Harada et al. BJU INTERNATIONAL
- Human renal cancer stem cells
- (2012) Benedetta Bussolati et al. CANCER LETTERS
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal stem cells and their implications for kidney cancer
- (2012) Håkan Axelson et al. SEMINARS IN CANCER BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started